Sai Life SciencesNSE:SAILIFE -1.09%18 Quick Ratio is 1.51 as of Mar. 2026, which is 30% above its 10-year median of 1.16. GuruFocus rates NSE:SAILIFE with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Sai Life Sciences ranks worse than 54.67% on this metric.
Sai Life Sciences has a quick ratio of 1.51. It generally indicates good short-term financial strength.
The historical rank and industry rank for Sai Life Sciences's Quick Ratio or its related term are showing as below:
NSE:SAILIFE'
s Quick Ratio Range Over the Past 10 Years
Min: 1.09 Med: 1.16 Max: 1.89
Current: 1.51
During the past 5 years, Sai Life Sciences's highest Quick Ratio was 1.89. The lowest was 1.09. And the median was 1.16.
NSE:SAILIFE's Quick Ratio is ranked worse than 54.67% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.715
vs NSE:SAILIFE: 1.51
Sai Life Sciences (NSE:SAILIFE) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Sai Life Sciences Quick Ratio Related Terms
Sai Life Sciences Quick Ratio Historical Data
* Premium members only.
The historical data trend for Sai Life Sciences's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SAILIFE vs TMO, DHR, IDXX: Quick Ratio Comparison
For the Diagnostics & Research subindustry, Sai Life Sciences's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sai Life Sciences Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sai Life Sciences's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Sai Life Sciences's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Sai Life Sciences's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Life Sciences (NSE:SAILIFE) has a Quick Ratio of 1.51 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sai Life Sciences and its competitors. This is 30% above median its historical median of 1.16. Over the past decade, Sai Life Sciences' Quick Ratio has ranged from 1.09 to 1.89. According to the industry distribution chart, Sai Life Sciences ranks #117 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 54.7%.
Is Sai Life Sciences' Quick Ratio too high?
Sai Life Sciences' current Quick Ratio of 1.51 is 30% above median its 10-year median of 1.16. Over the past 10 years, this metric has ranged from a low of 1.09 to a high of 1.89. The Medical Diagnostics & Research industry median Quick Ratio is 1.72. Sai Life Sciences' value of 1.51 is 12% below this industry median. Based on the distribution chart, Sai Life Sciences ranks #117 out of 214 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sai Life Sciences ranks #117 out of 214 companies for Quick Ratio. This places Sai Life Sciences in the lower half of its industry. The industry median Quick Ratio is 1.72. Sai Life Sciences' value of 1.51 is 12% below this benchmark. Historically, Sai Life Sciences' own Quick Ratio has ranged from 1.09 to 1.89 over the past decade. While the company's 10-year median is 1.16 vs. the industry median of 1.72, Sai Life Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.72, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sai Life Sciences's current Quick Ratio of 1.51 is 12% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sai Life Sciences and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sai Life Sciences's current Quick Ratio is 1.51, which is 30% above median its own 10-year median of 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current Quick Ratio of 1.51. The current Quick Ratio is 1.51, which is 30% above median its 10-year median of 1.16 and 12% below the Medical Diagnostics & Research industry median of 1.72. Sai Life Sciences' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current Quick Ratio is 1.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score
Get the complete analysis for NSE:SAILIFE
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAILIFE has been successfully added to your 
